Abstract
Introduction: The covid-19 pandemic has become a global threat for the general public and health care workers and it has created major challenges for all healthcare sectors. The challenges created by this disease can vary in different countries depending on cultural, social, and economic factors. To explain the challenges of the Iranian health system in fighting the covid-19 pandemic from the managers’ and executive authorities’ viewpoints.
Methods
The present study is a basic-applied research performed using a qualitative approach. It has studied 30 managers of the hospitals and medical centers’ managers, and deputies of the Ministry of Health, and the universities of medical sciences which were selected by purposive and snowball sampling with the maximum variety in March-September 2020. Data collection was done through semi-structured interviews and content analysis was used to explain the challenges of the Iranian health system in fighting the covid-19 pandemic (2020).
Results
Most of the interviewees (87%) had a Ph.D. degree (34%), and 40% of the participants were graduated in management and health economy and policymaking fields. Analysis and synthesis of the data collected from the interviews led to the creation of 19 sub-themes and 12 main themes classified into four general scopes including the organizational factors, resources, management factors, and other factors.
Conclusion
Identifying the mentioned challenges can provide useful information for the managers and policymakers to develop appropriate plans and take the necessary measures for resolving the challenges and using the available resources to provide the most effective services.
References
[1] K. X. Nie, C. Wang, and X. W. Li, “Success of Big Infectious Disease Reimbursement Policy in China,” Inq. (United States), vol. 57, 2020, doi: 10.1177/0046958020907788.
[2] B. J. Silk, “Infectious Disease Threats and Opportunities for Prevention,” J. Public Heal. Manag. Pract., vol. 24, no. 6, pp. 503–505, 2018, doi: 10.1097/PHH.0000000000000910.
[3] C. Huang et al., “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China,” Lancet, vol. 395, no. 10223, pp. 497–506, 2020, doi: 10.1016/S0140-6736(20)30183-5.
[4] N. Zhu et al., “A novel coronavirus from patients with pneumonia in China, 2019,” N. Engl. J. Med., vol. 382, no. 8, pp. 727–733, 2020, doi: 10.1056/NEJMoa2001017.
[5] World Health Organization, “Novel Coronavirus (2019-nCoV) SITUATION REPORT - 1- 21 January 2020,” 2020.
[6] World Health Organization, “Novel Coronavirus(2019-nCoV) Situation Report – 22- 11 February 2020,” 2020. [Online]. Available: https://www.who.int/indonesia/news/novel-coronavirus/qa-for-public.
[7] World Health Organization, “Coronavirus disease 2019 (COVID-19) Situation Report – 47- 07 March 2020,” 2020.
[8] World Health Organization, “Coronavirus disease 2019 (COVID-19) Situation Report – 50- 10 March 2020,” 2020. [Online]. Available: https://pandemic.internationalsos.com/2019-ncov/ncov-travel-restrictions-flight-operations-and-screening%0Ahttps://www.cdc.gov/h1n1flu/who/.
[9] World Health Organization, “Coronavirus disease 2019 (COVID-19) Situation Report – 51- 11 March 2020,” 2020.
[10] World Health Organization, “Coronavirus disease 2019 (COVID-19) Situation Report – 52- 12 March 2020,” 2020.
[11] Worldometer, “COVID-19 CORONAVIRUS PANDEMIC,” 2021. https://www.worldometers.info/coronavirus/.
[12] ECLAC, “Special Report: The social challenge in times of COVID-19,” 2020. [Online]. Available: https://repositorio.cepal.org/bitstream/handle/11362/45544/1/S2000324_en.pdf.
[13] J. W. Goodell, “COVID-19 and finance: Agendas for future research,” Financ. Res. Lett., vol. 35, no. March, 2020, doi: 10.1016/j.frl.2020.101512.
[14] M. Nicola et al., “The socio-economic implications of the coronavirus pandemic (COVID-19): A review,” Int. J. Surg., vol. 78, no. March, pp. 185–193, 2020, doi: 10.1016/j.ijsu.2020.04.018.
[15] C. C. Lai, T. P. Shih, W. C. Ko, H. J. Tang, and P. R. Hsueh, “Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges,” Int. J. Antimicrob. Agents, vol. 55, no. 3, p. 105924, 2020, doi: 10.1016/j.ijantimicag.2020.105924.
[16] K. Iyengar, A. Mabrouk, V. K. Jain, A. Venkatesan, and R. Vaishya, “Learning opportunities from COVID-19 and future effects on health care system,” Diabetes Metab. Syndr. Clin. Res. Rev., vol. 14, no. 5, pp. 943–946, 2020, doi: 10.1016/j.dsx.2020.06.036.
[17] T. Singhal, “A Review on COVID19 disease- 2019 (COVID-19),” Indian J. Pediatr., vol. 87, no. April, pp. 281–286, 2020.
[18] C. Lionis and E. Petelos, “Challenges, priorities and tasks for the generalists at the time of COVID-19 pandemic,” Eur. J. Gen. Pract., vol. 26, no. 1, pp. 104–105, 2020, doi: 10.1080/13814788.2020.1791073.
[19] A. Tong, P. Sainsbury, and J. Craig, “Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups,” Int. J. Qual. Heal. Care, vol. 19, no. 6, pp. 349–357, 2007, doi: 10.1093/intqhc/mzm042.
[20] S. Elo and H. Kyngas, “The qualitative content analysis process,” JAN Reserch Metodol., pp. 107–115, 2007, doi: 10.1111/j.1365-2648.2007.04569.x.
[21] Krippendorff K H, Content analysis: An introduction to its methodology, Third Edit. Sage, 2012.
[22] G. Guest, A. Bunce, and L. Johnson, “How Many Interviews Are Enough?: An Experiment with Data Saturation and Variability,” Field methods, vol. 18, no. 1, pp. 59–82, 2006, doi: 10.1177/1525822X05279903.
[23] Polit DF. Beck CT, Essentials of nursing research: appraising evidence for nursing practice, 8th ed. Lippincott Williams & Wilkins, 2014.
[24] L. Y. Guba EG, Competing paradigms in qualitative research. Handbook of qualitative research., 2nd ed. 1994.
[25] K. K. Sahu, A. K. Mishra, and A. Lal, “A twin challenge to handle: COVID-19 with pregnancy,” J. Med. Virol., vol. 92, no. 10, pp. 1718–1720, 2020, doi: 10.1002/jmv.25784.
[26] E. Tello-Leal, O. Chiotti, and P. D. Villarreal, “Process-oriented integration and coordination of healthcare services across organizational boundaries,” J. Med. Syst., vol. 36, no. 6, pp. 3713–3724, 2012, doi: 10.1007/s10916-012-9844-0.
[27] J. A. V. Romero, S. J. Del Llano, C. D. P. Heredero, and M. Nuijten, “Relational coordination and healthcare management in lung cancer,” World J. Clin. Cases, vol. 2, no. 12, pp. 757–768, 2014, doi: 10.12998/wjcc.v2.i12.757.
[28] H. Ashrafi-Rizi and Z. Kazempour, “The challenges of information services related to the COVID-19 crisis,” J. Mil. Med., vol. 22, no. 2, pp. 207–209, 2020, doi: 10.30491/JMM.22.2.207.
[29] Y. M. Arabi, S. Murthy, and S. Webb, “COVID-19: a novel coronavirus and a novel challenge for critical care,” Intensive Care Med., vol. 46, no. 5, pp. 833–836, 2020, doi: 10.1007/s00134-020-05955-1.
[30] J. M. Fegert, B. Vitiello, P. L. Plener, and V. Clemens, “Challenges and burden of the Coronavirus 2019 (COVID-19) pandemic for child and adolescent mental health: A narrative review to highlight clinical and research needs in the acute phase and the long return to normality,” Child Adolesc. Psychiatry Ment. Health, vol. 14, no. 1, pp. 1–11, 2020, doi: 10.1186/s13034-020-00329-3.
[31] H. M. Al-Dorzi et al., “The critical care response to a hospital outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) infection: an observational study,” Ann. Intensive Care, vol. 6, no. 1, 2016, doi: 10.1186/s13613-016-0203-z.
[32] M. Najafi, M. Arab, M. Sayed Mahmudi, M. Nazari, R. Rajaie, and B. Pour Agha, “Identifying the contributing factors to the management of hospitals during the outbreak of corona virus based on the experience of the managers of medical training centers at alborz university f medical sciences: A qualitative study,” Alborz, 2020.